Literature DB >> 22460113

Deal watch: Biogen acquires Stromedix to pursue novel fibrosis therapy.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22460113     DOI： 10.1038/nrd3708

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Strategies for treating idiopathic pulmonary fibrosis.

Authors:  R M du Bois
Journal:  Nat Rev Drug Discov       Date:  2010-01-22       Impact factor: 84.694
  1 in total
  3 in total

Review 1.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

2.  Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-29

Review 3.  Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer.

Authors:  Joseph W O'Connor; Esther W Gomez
Journal:  Clin Transl Med       Date:  2014-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.